Cilostazol
Loading...Cilostazol Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Cilostazol tablets are indicated for the reduction of symptoms of intermittent claudication, as indicated by an increased walking distance.
History
There is currently no drug history available for this drug.
Other Information
DESCRIPTION
Cilostazol is a quinolinone derivative that inhibits cellular phosphodiesterase (more specific for phosphodiesterase III). The empirical formula of cilostazol is C20H27N5O2, and its molecular weight is 369.46. Cilostazol is 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone, CAS-73963-72-1. The structural formula is:
Cilostazol occurs as white to off-white crystals or as a crystalline powder that is slightly soluble in methanol and ethanol, and is practically insoluble in water, 0.1 N HCl, and 0.1 N NaOH.
Cilostazol tablets for oral administration are available as 50 mg or 100 mg round, white debossed tablets. Each tablet, in addition to the active ingredient, contains the following inactive ingredients: carboxymethylcellulose calcium, corn starch, hypromellose, magnesium stearate and microcrystalline cellulose.
Sources
Cilostazol Manufacturers
-
Stat Rx Usa Llc
![Cilostazol Tablet [Stat Rx Usa Llc]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Cilostazol | Stat Rx Usa Llc
DOSAGE AND ADMINISTRATION
The recommended dosage of cilostazol is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of Therapy: The available data suggest that the dosage of cilostazol can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Physicians Total Care, Inc.
Cilostazol | Physicians Total Care, Inc.
The recommended dosage of cilostazol is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of TherapyThe available data suggest that the dosage of cilostazol can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Golden State Medical Supply, Inc.
Cilostazol | Golden State Medical Supply, Inc.
The recommended dosage of cilostazol is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of TherapyThe available data suggest that the dosage of cilostazol can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Apotex Corp.
Cilostazol | Aurobindo Pharma Limited
2.1 Dosage in Narcolepsy and Obstructive Sleep Apnea (OSA)The recommended dosage of modafinil tablets for patients with narcolepsy or OSA is 200 mg taken orally once a day as a single dose in the morning.
2.2 Dosage in Shift Work Disorder (SWD)
Doses up to 400 mg/day, given as a single dose, have been well tolerated, but there is no consistent evidence that this dose confers additional benefit beyond that of the 200 mg/day dose [see Clinical Pharmacology (12.3) and Clinical Studies (14.1, 14.2)].The recommended dosage of modafinil tablets for patients with SWD is 200 mg taken orally once a day as a single dose approximately 1 hour prior to the start of their work shift.
2.3 Dosage Modifications in Patients with Severe Hepatic ImpairmentIn patients with severe hepatic impairment, the dosage of modafinil tablets should be reduced to one-half of that recommended for patients with normal hepatic function [see Use in Specific Populations (8.6) and Clinical Pharmacology (12.3)].
2.4 Use in Geriatric PatientsConsideration should be given to the use of lower doses and close monitoring in geriatric patients [see Use in Specific Populations (8.5)].
-
Corepharma Llc.
Cilostazol | Corepharma Llc.
The recommended dosage of cilostazol is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of TherapyThe available data suggest that the dosage of cilostazol can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Cardinal Health
Cilostazol | Cardinal Health
The recommended dosage of cilostazol tablets is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of TherapyThe available data suggest that the dosage of cilostazol tablets can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Roxane Laboratories, Inc
Cilostazol | Roxane Laboratories, Inc
The recommended dosage of cilostazol is 100 mg twice daily taken at least half an hour before or two hours after breakfast and dinner.
A dose reduction to 50 mg twice daily should be considered during co-administration with strong or moderate CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, erythromycin and diltiazem) and during co-administration with CYP2C19 inhibitors (e.g., ticlopidine, fluconazole and omeprazole. (see PRECAUTIONS and Pharmacokinetic and Pharmacodynamic Drug-Drug Interactions) twice daily.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced. If symptoms are unimproved after 3 months, discontinue cilostazol.
Discontinuation of TherapyThe available data suggest that the dosage of cilostazol can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Golden State Medical Supply, Inc.
Cilostazol | Golden State Medical Supply, Inc.
The recommended dosage of cilostazol is 100 mg twice daily taken at least half an hour before or two hours after breakfast and dinner. A dose reduction to 50 mg twice daily should be considered during co-administration with strong or moderate CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, erythromycin and diltiazem) and during co-administration with CYP2C19 inhibitors (e.g., ticlopidine, fluconazole and omeprazole. (see PRECAUTIONS and Pharmacokinetic and Pharmacodynamic Drug-Drug Interactions) twice daily
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced. If symptoms are unimproved after 3 months, discontinue cilostazol.
Discontinuation of Therapy
The available data suggest that the dosage of cilostazol can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Bryant Ranch Prepack
Cilostazol | Bryant Ranch Prepack
The recommended dosage of Cilostazol Tablets USP is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of TherapyThe available data suggest that the dosage of Cilostazol Tablets USP can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Eon Labs, Inc.
Cilostazol | Eon Labs, Inc.
2.1 Recommended dosageThe recommended dosage of cilostazol tablets is 100 mg twice daily taken at least half an hour before or two hours after breakfast and dinner.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced. If symptoms are unimproved after 3 months, discontinue cilostazol tablets.
2.2 Dosage Reduction with CYP3A4 and CYP2C19 InhibitorsReduce dose to 50 mg twice daily when coadministered with strong or moderate inhibitors of CYP3A4 (e.g., ketoconazole, itraconazole, erythromycin, and diltiazem) or inhibitors of CYP2C19 (e.g., ticlopidine, fluconazole, and omeprazole) [see DRUG INTERACTIONS (7.1)].
-
Lake Erie Medical Dba Quality Care Products Llc
Cilostazol | Lake Erie Medical Dba Quality Care Products Llc
The recommended dosage of cilostazol tablets USP is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of TherapyThe available data suggest that the dosage of cilostazol tablets USP can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Lake Erie Medical Dba Quality Care Products Llc
Cilostazol | Lake Erie Medical Dba Quality Care Products Llc
The recommended dosage of cilostazol is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of TherapyThe available data suggest that the dosage of cilostazol can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Breckenridge Pharmaceutical, Inc.
Cilostazol | Breckenridge Pharmaceutical, Inc.
The recommended dosage of CILOSTAZOL is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of TherapyThe available data suggest that the dosage of CILOSTAZOL can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Ncs Healthcare Of Ky, Inc Dba Vangard Labs
Cilostazol | Ncs Healthcare Of Ky, Inc Dba Vangard Labs
The recommended dosage of cilostazol tablets USP is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of TherapyThe available data suggest that the dosage of cilostazol tablets, USP can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Ncs Healthcare Of Ky, Inc Dba Vangard Labs
Cilostazol | Ncs Healthcare Of Ky, Inc Dba Vangard Labs
The recommended dosage of cilostazol tablets USP is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of TherapyThe available data suggest that the dosage of cilostazol tablets, USP can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Bryant Ranch Prepack
Cilostazol | Bryant Ranch Prepack
The recommended dosage of cilostazol tablets is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during co-administration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem and during co-administration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of TherapyThe available data suggest that the dosage of cilostazol tablets can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Cardinal Health
Cilostazol | Cardinal Health
The recommended dosage of cilostazol is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of Therapy
The available data suggest that the dosage of cilostazol can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Biokey Inc.
Cilostazol | Biokey Inc.
The recommended dosage of cilostazol is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of Therapy: The available data suggest that the dosage of cilostazol can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Teva Pharmaceuticals Usa Inc
Cilostazol | Apotex Corp.
Famciclovir tablets may be taken with or without food.
2.1 Dosing Recommendation in Immunocompetent Adult PatientsHerpes labialis (cold sores)
The recommended dosage of famciclovir tablets for the treatment of recurrent herpes labialis is 1500 mg as a single dose. Therapy should be initiated at the first sign or symptom of herpes labialis (e.g., tingling, itching, burning, pain, or lesion).
Genital herpes
Recurrent episodes
The recommended dosage of famciclovir tablets for the treatment of recurrent episodes of genital herpes is 1000 mg twice daily for 1 day. Therapy should be initiated at the first sign or symptom of a recurrent episode (e.g., tingling, itching, burning, pain, or lesion).
Suppressive therapy
The recommended dosage of famciclovir tablets for chronic suppressive therapy of recurrent episodes of genital herpes is 250 mg twice daily.
Herpes zoster (shingles)
The recommended dosage of famciclovir tablets for the treatment of herpes zoster is 500 mg every 8 hours for 7 days. Therapy should be initiated as soon as herpes zoster is diagnosed.
2.2 Dosing Recommendation in HIV-Infected Adult PatientsRecurrent orolabial or genital herpes
The recommended dosage of famciclovir tablets for the treatment of recurrent orolabial or genital herpes in HIV-infected patients is 500 mg twice daily for 7 days. Therapy should be initiated at the first sign or symptom of a recurrent episode (e.g., tingling, itching, burning, pain, or lesion).
2.3 Dosing Recommendation in Patients with Renal ImpairmentDosage recommendations for adult patients with renal impairment are provided in Table 1 [see Use in Specific Populations (8.6), Clinical Pharmacology (12.3)].
Table 1: Dosage Recommendations for Adult Patients with Renal Impairment * Hemodialysis Indication and Normal Dosage
Regimen Creatinine Clearance
(mL/min) Adjusted Dosage
Regimen Dose (mg) Dosing Interval Single-Day Dosing Regimens Recurrent Genital Herpes
1000 mg every 12 hours for 1 day ≥60 1000 every 12 hours for 1 day 40-59 500 every 12 hours for 1 day 20-39 500 single dose <20 250 single dose HD* 250 single dose following
dialysis Recurrent Herpes Labialis
1500 mg single dose ≥60 1500 single dose 40-59 750 single dose 20-39 500 single dose <20 250 single dose HD* 250 single dose following
dialysis Multiple-Day Dosing Regimens Herpes zoster
500 mg every 8 hours ≥ 60 500 every 8 hours 40-59 500 every 12 hours 20-39 500 every 24 hours <20 250 every 24 hours HD 250 following each dialysis Suppression of Recurrent
Genital Herpes
250 mg every 12 hours ≥40 250 every 12 hours 20-39 125 every 12 hours <20 125 every 24 hours HD* 125 following each dialysis Recurrent Orolabial
or Genital Herpes
in HIV-Infected Patients
500 mg every 12 hours ≥40 500 every 12 hours 20-39 500 every 24 hours <20 250 every 24 hours HD* 250 following each dialysis
-
Preferred Pharmaceuticals, Inc.
Cilostazol | Preferred Pharmaceuticals, Inc.
The recommended dosage of cilostazol is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of Therapy
The available data suggest that the dosage of cilostazol can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
American Health Packaging
Cilostazol | American Health Packaging
The recommended dosage of cilostazol is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of Therapy
The available data suggest that the dosage of cilostazol can be reduced or discontinued without rebound (i.e., platelet hyperaggregability). -
Carilion Materials Management
Cilostazol | Carilion Materials Management
The recommended dosage of Cilostazol Tablets USP is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of TherapyThe available data suggest that the dosage of Cilostazol Tablets USP can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
-
Carilion Materials Management
Cilostazol | Carilion Materials Management
The recommended dosage of Cilostazol Tablets USP is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner. A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced.
Discontinuation of TherapyThe available data suggest that the dosage of Cilostazol Tablets USP can be reduced or discontinued without rebound (i.e., platelet hyperaggregability).
![Cilostazol Tablet [Physicians Total Care, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=151d1497-7655-44ce-8e97-dd1cd91f686a&name=5411.jpg)
![Cilostazol Tablet [Golden State Medical Supply, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b4509afc-539b-4d7f-97d4-5e9c98c2f65a&name=LabelGraphic-100mg60s.jpg)
![Cilostazol Tablet [Apotex Corp.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f51ca007-3955-4540-a88a-0ddae8d8e8ab&name=modafinil-fig1.jpg)
![Cilostazol Tablet [Corepharma Llc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1162b345-b45c-448e-a399-b3cce63ea37b&name=cilostazol-tablets-usp-6.jpg)
![Cilostazol Tablet [Cardinal Health]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8e49409b-6bb1-4b8a-8a5b-4cb1a291660e&name=8e49409b-6bb1-4b8a-8a5b-4cb1a291660e-04.jpg)
![Cilostazol Tablet [Roxane Laboratories, Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9ffdb1e8-fdc8-44d4-b558-210954138b2f&name=100-mg-60-count.jpg)
![Cilostazol Tablet [Golden State Medical Supply, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=d801230d-0344-4cea-bb04-5818e931bb66&name=cilostazol-100mg60s.jpg)
![Cilostazol Tablet [Bryant Ranch Prepack]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=81d39216-a241-4ab1-8937-171f96c28f3c&name=46441.jpg)
![Cilostazol Tablet [Eon Labs, Inc.]](https://www.recallguide.org/wp-content/themes/bootstrap/assets/img/drug-image-placeholder.jpg)
![Cilostazol Tablet [Lake Erie Medical Dba Quality Care Products Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f86d303a-eaa2-4335-bfce-1952404ae96c&name=Cilostazol100mgPiramal.jpg)
![Cilostazol Tablet [Lake Erie Medical Dba Quality Care Products Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=20a05739-46a6-47ca-ae61-4341d028460e&name=Cilostazol100mgApotex.jpg)
![Cilostazol Tablet [Breckenridge Pharmaceutical, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c4597231-fec0-435d-a0c6-8c237e3d60a9&name=cilostazol-05.jpg)
![Cilostazol Tablet [Ncs Healthcare Of Ky, Inc Dba Vangard Labs]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=5f4fc5df-5077-4cad-a5dc-1b54a73904cc&name=cilostazol-4.jpg)
![Cilostazol Tablet [Ncs Healthcare Of Ky, Inc Dba Vangard Labs]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=66e0ed7b-e29a-45ee-82bb-3db6142c2697&name=cilostazol-tablet-4.jpg)
![Cilostazol Tablet [Bryant Ranch Prepack]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c9866259-deab-46af-b8e6-880dba7bfb96&name=51121.jpg)
![Cilostazol Tablet [Cardinal Health]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=85fc5079-ec88-450e-9c0b-bca7340cad4f&name=b2076256-b139-4e39-b4f4-85886069d995-05.jpg)
![Cilostazol Tablet [Biokey Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=7496843f-0c4d-46e1-af23-850213b38f9e&name=Cilostazol_100mg_60.jpg)
![Cilostazol Tablet [Teva Pharmaceuticals Usa Inc]](http://www.recallguide.org/wp-content/themes/bootstrap/assets/img/drug-image-placeholder.jpg)
![Cilostazol Tablet [Preferred Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=6a8b9b84-9942-4edd-8df9-319880d2feab&name=cilo-imtb-100mg-lbl-30.jpg)
![Cilostazol Tablet [American Health Packaging]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f1ccc10a-e42d-44f7-b7da-5538f3b39461&name=CilostazolTablets,USP50mgLabel.jpg)
![Cilostazol Tablet [Carilion Materials Management]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=eb510ad0-dce7-4714-afc6-7959a151ad28&name=68151-3844.jpg)
![Cilostazol Tablet [Carilion Materials Management]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=50fc64ac-7eb3-4bab-8de2-83cd5404d169&name=68151-4123.jpg)
Login To Your Free Account